These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3369002)
1. Serum and tissue levels of platinum after cisplatinum instillation of the rat bladder. Wagner HA; Groebe G; Engelmann U Urol Res; 1988; 16(2):85-8. PubMed ID: 3369002 [TBL] [Abstract][Full Text] [Related]
2. Permeability of the rat bladder to Cisplatinum under different conditions: comparison with Mitomycin C and Adriamycin. Engelmann U; Oelsner G; Bürger RA; Wagner H Urol Res; 1983; 11(1):39-42. PubMed ID: 6407169 [TBL] [Abstract][Full Text] [Related]
3. Adriamycin permeability of the rat bladder under different conditions. Engelmann U; Bürger RA; Rumpelt JH; Jacobi GH J Urol; 1983 Apr; 129(4):862-4. PubMed ID: 6842726 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat. Vadiei K; Siddik ZH; Khokhar AR; al-Baker S; Sampedro F; Perez-Soler R Cancer Chemother Pharmacol; 1992; 30(5):365-9. PubMed ID: 1505075 [TBL] [Abstract][Full Text] [Related]
5. Experimental investigations on the absorption of intravesically instilled mitomycin C in the urinary bladder of the rat. Engelmann U; Bürger R; Jacobi GH Eur Urol; 1982; 8(3):176-81. PubMed ID: 6804242 [TBL] [Abstract][Full Text] [Related]
6. Dimethylsulfoxide enhances the absorption of chemotherapeutic drug instilled into the bladder. Hashimoto H; Tokunaka S; Sasaki M; Nishihara M; Yachiku S Urol Res; 1992; 20(3):233-6. PubMed ID: 1615585 [TBL] [Abstract][Full Text] [Related]
8. Regional chemotherapy for bladder neoplasms using continuous intravesical infusion of doxorubicin: impact of concomitant administration of dimethyl sulfoxide on drug absorption and antitumor activity. See WA; Xia Q J Natl Cancer Inst; 1992 Apr; 84(7):510-5. PubMed ID: 1545441 [TBL] [Abstract][Full Text] [Related]
10. Organ distribution of Adriamycin after intravesical instillation with or without Tween 80 in the rat. Hellsten S; Axelsson B; Eksborg S; Lindkvist C Urol Res; 1988; 16(4):325-7. PubMed ID: 3176207 [TBL] [Abstract][Full Text] [Related]
11. Production of high specific activity (195m) Pt-cisplatinum at South African Nuclear Energy Corporation for Phase 0 clinical trials in healthy individual subjects. Zeevaart JR; Wagener J; Marjanovic-Painter B; Sathekge M; Soni N; Zinn C; Perkins G; Smith SV J Labelled Comp Radiopharm; 2013; 56(9-10):495-503. PubMed ID: 24285528 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of the platinum analog [Pt(cis-dach)(DPPE)-2NO3] on histocultured human patient bladder tumors and cancer cell lines. Chang SG; Jung JC; Rho YS; Huh JS; Kim JI; Hoffman RM Anticancer Res; 1996; 16(6B):3423-8. PubMed ID: 9042201 [TBL] [Abstract][Full Text] [Related]
13. Permeability characteristics of the rat urinary bladder in experimental cystitis and after overdistension. Hohlbrugger G; Lentsch P; Pfaller K; Madersbacher H Urol Int; 1985; 40(4):211-6. PubMed ID: 3901473 [TBL] [Abstract][Full Text] [Related]
14. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats. Uozumi J; Litterst CL J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443 [TBL] [Abstract][Full Text] [Related]
15. Phase I study of KRP-116D, a 50% w/w dimethyl sulfoxide aqueous solution, on the systemic absorption from bladder by intravesical instillation in healthy Japanese subjects. Shimada H; Yono M; Hojo Y; Hamamura Y; Ootsuki A Low Urin Tract Symptoms; 2020 May; 12(2):150-154. PubMed ID: 31696635 [TBL] [Abstract][Full Text] [Related]
16. Instillation of liposomes vs dimethyl sulphoxide or pentosan polysulphate for reducing bladder hyperactivity. Tyagi P; Hsieh VC; Yoshimura N; Kaufman J; Chancellor MB BJU Int; 2009 Dec; 104(11):1689-92. PubMed ID: 19594739 [TBL] [Abstract][Full Text] [Related]
17. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. II. On the effects of intravesical instillation of cis-diamminedichloroplatinum in bladder cancer patients]. Hirao Y; Iwai A; Moriya A; Matsuki H; Yoshida Y; Komada S; Sasaki K; Kubota K; Sanma S; Babaya K Hinyokika Kiyo; 1985 Sep; 31(9):1565-73. PubMed ID: 4083214 [TBL] [Abstract][Full Text] [Related]
18. Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patients. Pujol JL; Cupissol D; Gestin-Boyer C; Bres J; Serrou B; Michel FB Cancer Chemother Pharmacol; 1990; 27(1):72-5. PubMed ID: 2173980 [TBL] [Abstract][Full Text] [Related]
19. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin. Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546 [TBL] [Abstract][Full Text] [Related]
20. Bladder wall penetration of intravesical mitomycin C in dogs. Wientjes MG; Dalton JT; Badalament RA; Drago JR; Au JL Cancer Res; 1991 Aug; 51(16):4347-54. PubMed ID: 1907883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]